The new standard for controlling cardiac resynchronization therapy in heart failure
Although cardiac resynchronization therapy (CRT) is successful in treating heart failure, there is room for improvement, as 30–40% of heart failure patients do not respond to the therapy. Learn how we can specifically maximize the individual response to CRT in Nico Drost's presentation.
Zign Group
Nieuwegein,
Netherlands
Speaker
Nico Drost, Zign Group, CEO